SC: Clarificatory Statement Does Not Constitute a Binding Undertaking for Contempt Proceedings || Supreme Court: Litigant Cannot be Worse Off for Filing an Appeal under ‘No Reformatio in Peius’ || Orissa HC: Article 22(1) Arrest Rights Pre-Exist, Written Grounds Ruling Not Prospective || Kerala HC: Kissing a Child’s Penis Constitutes Penetrative Sexual Assault under POCSO || Madras HC: Married Daughter Cannot be Denied Compassionate Appointment Solely for Her Marriage || Bombay High Court: Child Welfare Prevails as ‘Joint Parenting’ is Not Recognised in Indian Law || Kerala HC: Minor’s Consent or Relationship with Accused Holds No Relevance under POCSO Act || Bombay HC: Failure to Prove Exact Quantum of Loss Does Not Bar Compensation || CCPA Fines Dial4Trade Rs. 10 Lakh for Online Ammonium Nitrate Listing Featuring Blast Images || Supreme Court: Multiple Cases Alone Cannot Justify an Externment Order

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :